In vitro efficacy of Linezolid on clinical strains of Mycobacterium tuberculosis and other mycobacteria

被引：0
|
作者：
Molicotti, Paola [1 ]
Ortu, Silvia [1 ]
Bua, Alessandra [1 ]
Cannas, Sara [1 ]
Sechi, Leonardo A. [1 ]
Zanetti, Stefania [1 ]
机构：
[1] Univ Sassari, Dip Sci Biomed, Sez Microbiol Clin & Sperimentale, Inst Microbiol, I-07100 Sassari, Italy
来源：
NEW MICROBIOLOGICA | 2006年 / 29卷 / 04期
关键词：
Linezolid; Mycobacterium spp; proportional method; MIC;
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Linezolid, an oxazolidinone that acts by inhibiting protein synthesis, was evaluated in strains of tuberculosis and non-tubercular mycobacteria resistant to one or more drugs isolated in northern Sardinia. The in vitro activity of Linezolid (Pfizer) was assessed on different isolates of Mycobacterium spp. from clinical samples by the Proportional Method. Linezolid demonstrated an excellent activity against the 24 strains of M. tuberculosis and against M. gordonae, M. marinum, M. aurum, M. phlei, and M. avium, with MIC values ranging from 0.5 to 2 mu g/ml. Linezolid can be used in combination with the standard antitubercular medications, or as an effective therapeutic alternative in infections caused by M. tuberculosis or by other species of non-tubercular mycobacteria.
引用
收藏
页码：275 / 280
页数：6
相关论文
共 50 条
  • [21] The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
    Henao-Tamayo, Marcela
    Shanley, Crystal A.
    Verma, Deepshikha
    Zilavy, Andrew
    Stapleton, Margaret C.
    Furney, Synthia K.
    Podell, Brendan
    Orme, Ian M.
    PLOS ONE, 2015, 10 (09):
  • [22] First linezolid-resistant clinical isolates of Mycobacterium tuberculosis
    Richter, Elvira
    Ruesch-Gerdes, Sabine
    Hillemann, Doris
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1534 - 1536
  • [23] Causes of and clinical sequelae of delays in reporting species identification of mycobacteria other than Mycobacterium tuberculosis and Mycobacterium avium complex
    Ooi, Say Tat
    Fekete, Thomas
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (01) : 69 - 73
  • [24] Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase
    Kratky, Martin
    Vinsova, Jarmila
    Novotna, Eva
    Stolarikova, Jirina
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 53 : 1 - 9
  • [25] In vitro efficacy of acetohydroxyacid synthase inhibitors against clinical strains of Mycobacterium tuberculosis isolated from a hospital in Beijing, China
    Dong, Mei
    Wang, Di
    Jiang, Ying
    Zhao, Li
    Yang, Caie
    Wu, Chun
    SAUDI MEDICAL JOURNAL, 2011, 32 (11) : 1122 - 1126
  • [26] In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants
    Hillemann, Doris
    Ruesch-Gerdes, Sabine
    Richter, Elvira
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) : 800 - 801
  • [27] In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis
    Rodríguez, JC
    Ruiz, M
    López, M
    Royo, G
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (06) : 464 - 467
  • [28] DISEASE IN CHILDREN DUE TO MYCOBACTERIA OTHER THAN MYCOBACTERIUM-TUBERCULOSIS
    LINCOLN, EM
    GILBERT, LA
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1972, 105 (05): : 683 - +
  • [29] DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS FROM OTHER MYCOBACTERIA BY SODIUM SALICYLATE SUSCEPTIBILITY
    TSUKAMURA, IM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1962, 86 (01): : 81 - &
  • [30] SYNOVIAL TISSUE INFECTIONS DUE TO MYCOBACTERIA OTHER THAN MYCOBACTERIUM TUBERCULOSIS
    KELLY, PJ
    KARLSON, AG
    WEED, LA
    LIPSCOMB, PR
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1967, A 49 (07): : 1474 - &
12345